Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy

Clinical Infectious Diseases

Volumn 47, Issue 11, 2008, Pages 1372-1379

  Gershman, Mark D ^a,k   Kennedy, Donald J ^b   Noble Wang, Judith ^a   Kim, Curi ^a,c   Gullion, Jessica ^e   Kacica, Marilyn ^g   Jensen, Bette ^a   Pascoe, Neil ^f   Saiman, Lisa ^h   McHale, Jean ⁱ   Wilkins, Melinda ^d   Schoonmaker Bopp, Dianna ^g   Clayton, Joshua ^c,j   Arduino, Matthew ^a   Srinivasan, Arjun ^a  

^a NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^e Denton County Health Department   (United States)

^f TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^g NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^h Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

ⁱ McHale Institute   (United States)

^j South Dakota Department of Health   (United States)

^k CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; SODIUM CHLORIDE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BIOFILM; BLOOD CULTURE; BLOOD SAMPLING; CHILD; DEVICE INFECTION; EPIDEMIC; FEMALE; HUMAN; INDWELLING CATHETER; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; PRIORITY JOURNAL; PSEUDOMONAS FLUORESCENS; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SCANNING ELECTRON MICROSCOPY; SYRINGE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; BLOOD; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS INFECTIONS; SODIUM CHLORIDE;

EID: 55849110038     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592968     Document Type: Article

References (18)

1. Food and Drug Administration. Compliance policy guide, chapter 4, section 460.200: pharmacy compounding. Available at: http://www.fda.gov/ora/ compliance_ref/cpg/cpgdrg/cpg460-200.html. Accessed 4 April 2008.
2. Newton DW. Compounding paradox: taught less and practiced more. Am J Pharm Educ 2003; 67:12-4.
3. Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy - United States, July-November 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1109-12.
4. Civen R, Vugia DJ, Alexander R, et al. Outbreak of Serratia marcescens infections following injection of betamethasone compounded at a community pharmacy. Clin Infect Dis 2006; 43:831-7.
5. Centers for Disease Control and Prevention. Pseudomonas bloodstream infections associated with a heparin/saline flush - Missouri, New York, Texas, and Michigan, 2004-2005. MMWR Morb Mortal Wkly Rep 2005; 54:269-72.
6. Donlan RM, Murga R, Bell M, et al. Protocol for detection of biofilms on needleless connectors attached to central venous catheters. J Clin Microbiol 2001; 39:750-3.
7. Maslow J, Slutsky A, Arbeit R. Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing D, Smith T, Tenover F, White T, eds. Diagnostic molecular microbiology: principles and applications. Washington, DC: ASM Press, 1993.
8. Centers for Disease Control and Prevention. Update: delayed onset Pseudomonas fluorescens bloodstream infections after exposure to contaminated heparin flush - Michigan and South Dakota, 2005-2006. MMWR Morb Mortal Wkly Rep 2006; 55:961-3.
9. Khabbaz RF, Arnow PM, Highsmith AK, et al. Pseudomonas fluorescens bacteremia from blood transfusion. Am J Med 1984; 76:62-8.
10. Scott J, Boulton FE, Govan JR, Miles RS, McClelland DB, Prowse CV. A fatal transfusion reaction associated with blood contaminated with Pseudomonas fluorescens. Vox Sang 1988; 54:201-4.
11. Hsueh PR, Teng LJ, Pan HJ, et al. Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J Clin Microbiol 1998; 36:2914-7.
12. Food and Drug Administration. Statement by Steven K. Galson, M.D., M.P.H., to Senate Committee on Health, Education, Labor, and Pensions hearing on "Federal and state role in pharmacy compounding and reconstitution: exploring the right mix to protect patients." 2003. Available at: http://www.fda.gov/ola/2003/pharmacycompound1023.html. Accessed 4 April 2008.
13. Douard MC, Arlet G, Longuet P, et al. Diagnosis of venous access port-related infections. Clin Infect Dis 1999; 29:1197-202.
14. Raad I. Intravascular-catheter-related infections. Lancet 1998; 351:893-8.
15. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001; 33:1387-92.
16. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167-93.
17. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-32.
18. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-72.